Clinical Trials
22 trialsEvaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Ruijin Hospital
RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas
The First Affiliated Hospital with Nanjing Medical University
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution
Northwestern University
Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine
West China Hospital
Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
Shanghai Zhongshan Hospital
Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma
Affiliated Hospital to Academy of Military Medical Sciences
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation
Affiliated Hospital to Academy of Military Medical Sciences
Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL
Institute of Hematology & Blood Diseases Hospital, China
A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy
Zhujiang Hospital
Autologous Bedside CD19 CAR T-cell Therapy for B-ALL
The General Hospital of Western Theater Command
Allogeneic UCB-derived CAR-T for B-ALL
The General Hospital of Western Theater Command
CITY
Assistance Publique - Hôpitaux de Paris
Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)
Sun Yat-sen University
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
Nationwide Children's Hospital
CAR-T，MTD
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
Starna Therapeutics
The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine
Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients
University of Salamanca
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
The First Affiliated Hospital of Soochow University
Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Salarius Pharmaceuticals, LLC
CARTD-BG-1
Fundacion Clinic per a la Recerca Biomédica